References
- For a recent review see Skotnicki, J. S., and Levin, J. I. (2003). Annu. Rep. Med. Chem., 38, 153–162.
- For examples of small molecule TACE inhibitors see (a) Musso, D. L., Andersen, M. W., Andrews, R. C., Austin, R., Beaudet, E. J., Becherer, J. D., Bubacz, D. G., Bickett, D. M., Chan, J. H., Conway, J. G., Cowan, D. J., Gaul, M. D., Glennon, K. C., Hedeen, K. M., Lambert, M. H., Leesnitzer, M. A., McDougald, D. L., Mitchell, J. L., Moss, M. L., Rabinowitz, M. H., Rizzolio, M. C., Schaller, L. T., Stanford, J. B., Tippin, T. K., Warner, J. R., Whitesell, L. G., and Wiethe, R. W. (2001) Bioorg. Med. Chem. Lett., 11, 2147–2151. (b) Rabinowitz, M. H., Andrews, R. C., Becherer, J. D., Bickett, D. M., Bubacz, D. G., Conway, J. G., Cowan, D. J., Gaul, M., Glennon, K., Lambert, M. H., Leesnitzer, M. A., McDougald, D. L., Moss, M. L., Musso, D. L., and Rizzolio, M. C. (2001). J. Med. Chem., 44, 4252–4267. (c) Chen Duan, J. J.-W., Chen, L., Wasserman, Z. R., Lu, Z., Liu, R.-Q., Covington, M. B., Qian, M., Hardman, K. D., Magolda, R. L., Newton, R. C., Christ, D. D., Wexler, R. R., and Decicco, C. P. (2002). J. Med. Chem., 45, 4954–4957. (d) Letavic, M. A., Axt, M. Z., Barberia, J. T., Carty, T. J., Danley, D. E., Geoghegan, K. F., Halim, N. S., Hoth, L. R., Kamath, A. V., Laird, E. R., Lopresti-Morrow, L. L., McClure, K. F., Mitchell, P. G., Natarajan, V., Noe, M. C., Pandit, J., Reeves, L., Schulte, G. K., Snow, S. L., Sweeney, F. J., Tan, D. H., and Yu, C. H. (2002). Bioorg. Med. Chem. Lett., 12, 1387–1390.
- (a) Moss, M., Becherer, J. D., Milla, M., Pahel, G., Lambert, M., Andrews, R., Frye, S., Haffner, C., Cowan, D., Maloney, P., Dixon, E. P., Jansen, M., Vitek, M. P., Mitchell, J., Leesnitzer, T., Warner, J., Conway, J., Bickett, D. M., Bird, M., Priest, R., Reinhard, J., Lin, P. (1999). In Metalloproteinases as Targets for Anti-Inflammatory Drugs, edited by K. M. K. Bottomley, D. Bradshaw, and J. S. Nixon, Basel: Birkhauser Verlag, pp. 187-203. (b) Killar, L., White, J., Black, R., and Peschon, J. (1999). Ann. N. Y. Acad. Sci., 878, 442–452.
- (a) Chen, J. M.,Jin, G., Sung, A., and Levin, J. I. (2002). Bioorg. Med. Chem. Lett., 12, 1195–1198. (b) Levin, J. I., Chen, J. M., Du, M. T., Nelson, F. C., Killar, L. M., Skala, S., Sung, A., Jin, G., Cowling, R., Barone, D., March, C. J., Mohler, K. M., Black, R. A., and Skotnicki, J. S. (2002). Bioorg. Med. Chem. Lett., 12, 1199–1202.
- Gwaltney, S. L., Imade, H. M., Li, Q., Gehrke, L., Credo, R. B., Warner, R. B., Lee, J. Y., Kovar, P., Frost, D., Ng, S.-C., and Sham, H. L. (2001). Bioorg. Med. Chem. Lett., 11, 1671- 1673.
- Soll, R. M., Lu, T., Tomczuk, B., Illig, C. R., Fedde, C., Eisennagel, S., Bone, R., Murphy, L., Spurlino, J., and Salemme, F. R. (2000). Bioorg. Med. Chem. Lett., 10, 1- 4.
- (a) Weingarten, H., and Feder, J. (1985). Anal. Biochem., 147, 437–440. (b) Inhibitor concentrations were run in triplicate. MMP IC50 determinations were calculated from a 4-parameter logistic fit of the data within a single experiment.
- Jin, G., Huang, X., Black, R., Wolfson, M., Rauch, C., McGregor, H., Ellestad, G. A., and Cowling, R. (2002). Anal. Biochem., 302, 269–275.
- (a) Mohler, K. M., Sleath, P. R., Fitzner, J. N., Cerretti, D. P., Alderson, M., Kerwar, S. S., Torrance, D. S., Otten-Evans, C., Greenstreet, T., Weerawarna, K., Kronheim, S. R., Petersen, M., Gerhart, M., Kozlosky, C. J., March, C. J., and Black, R. A. (1994). Nature, 370, 218–220. (b) Levin, J. I., Chen, J. M., and Cole, D. C. (2000). WO 00/44709, 2000, Chem. Abstr., 133, 150908.
- Kansy, M., Senner, F., and Gubernator, K. (1998). J. Med. Chem. 41, 1007–1010.
- Schlondorff, J., Becherer, J. D., and Blobel, C. P. (2000). Biochem. J. 347, 131–138.